Teva Pharmaceutical Industries Limited OTC:TEVJF

Teva Pharmaceutical Industries Limited stock price today

$14.32
-4.18
-22.59%
Financial Health
0
1
2
3
4
5
6
7
8
9

Teva Pharmaceutical Industries Limited stock price monthly change

+7.62%
month

Teva Pharmaceutical Industries Limited stock price quarterly change

+7.62%
quarter

Teva Pharmaceutical Industries Limited stock price yearly change

+114.62%
year

Teva Pharmaceutical Industries Limited key metrics

Market Cap
12.22B
Enterprise value
27.54B
P/E
-3.73
EV/Sales
1.84
EV/EBITDA
-28.62
Price/Sales
0.58
Price/Book
1.01
PEG ratio
N/A
EPS
-0.40
Revenue
16.01B
EBITDA
4.40B
Income
-493M
Revenue Q/Q
4.67%
Revenue Y/Y
7.31%
Profit margin
-15.77%
Oper. margin
-14.06%
Gross margin
46.72%
EBIT margin
-14.06%
EBITDA margin
27.49%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Teva Pharmaceutical Industries Limited stock price history

Teva Pharmaceutical Industries Limited stock forecast

Teva Pharmaceutical Industries Limited financial statements

Teva Pharmaceutical Industries Limited (OTC:TEVJF): Profit margin
Jun 2023 3.87B -863M -22.25%
Sep 2023 3.85B 80M 2.08%
Dec 2023 4.45B 429M 9.63%
Mar 2024 3.83B -139M -3.63%
Teva Pharmaceutical Industries Limited (OTC:TEVJF): Analyst Estimates
Mar 2024 3.83B -139M -3.63%
Sep 2025 4.06B 766.50M 18.84%
Oct 2025 4.13B 794.67M 19.22%
Dec 2025 4.23B 894.26M 21.13%
  • Analysts Price target

  • Financials & Ratios estimates

Teva Pharmaceutical Industries Limited (OTC:TEVJF): Earnings per share (EPS)
2024-11-06 0.664 -0.3857
0%
Yield TTM
Teva Pharmaceutical Industries Limited (OTC:TEVJF): Payout ratio
Payout ratio 0%
Teva Pharmaceutical Industries Limited (OTC:TEVJF): Dividend Yield
2019 0.48%
2020
2021
2022
2023
Teva Pharmaceutical Industries Limited (OTC:TEVJF): Debt to assets
Jun 2023 43095000000 35.38B 82.11%
Sep 2023 42088000000 34.57B 82.15%
Dec 2023 43479000000 35.35B 81.31%
Mar 2024 42773000000 35.23B 82.37%
Teva Pharmaceutical Industries Limited (OTC:TEVJF): Cash Flow
Jun 2023 324M 302M -55M
Sep 2023 5M 184M -576M
Dec 2023 1.18B 301M -576M
Mar 2024 171M -215M -87M

Teva Pharmaceutical Industries Limited alternative data

Teva Pharmaceutical Industries Limited (OTC:TEVJF): Employee count
Aug 2023 34,004
Sep 2023 34,004
Oct 2023 34,004
Nov 2023 34,004
Dec 2023 34,004
Jan 2024 34,004
Feb 2024 37,000
Mar 2024 35,001
Apr 2024 35,001
May 2024 35,001
Jun 2024 35,001
Jul 2024 35,001

Teva Pharmaceutical Industries Limited other data

Teva Pharmaceutical Industries Limited (OTC:TEVJF): Insider trades (number of shares)
Period Buy Sel
Feb 2022 0 87692
Mar 2022 0 170531
May 2022 0 130000
Jul 2022 0 58163
Aug 2022 0 55500
Transaction Date Insider Security Shares Price per share Total value Source
Option
KALIF ELIYAHU SHARON officer: EVP, Chi.. Restricted Share Units 6,629 N/A N/A
Option
KALIF ELIYAHU SHARON officer: EVP, Chi.. Ordinary Shares 6,629 N/A N/A
Option
ZAKS TAL ZVI director
Restricted Share Units 12,205 N/A N/A
Option
ZAKS TAL ZVI director
Ordinary Shares 12,205 N/A N/A
Option
SCHULTZ KARE director, officer.. Restricted Share Units 116,389 N/A N/A
Option
SCHULTZ KARE director, officer.. Ordinary Shares 116,389 N/A N/A
Sale
KALIF ELIYAHU SHARON officer: EVP, Chi.. Ordinary Shares 55,500 $10.07 $558,719
Option
SHANI ELI officer: EVP,Global Marketing&P..
Restricted Share Units 1,581 N/A N/A
Option
SHANI ELI officer: EVP,Global Marketing&P..
Ordinary Shares 1,581 N/A N/A
Sale
STARK DAVID MATTHEW officer: Exec. VP Chief Legal O..
Ordinary Shares 58,163 $9.04 $525,619
  • What's the price of Teva Pharmaceutical Industries Limited stock today?

    One share of Teva Pharmaceutical Industries Limited stock can currently be purchased for approximately $14.32.

  • When is Teva Pharmaceutical Industries Limited's next earnings date?

    Unfortunately, Teva Pharmaceutical Industries Limited's (TEVJF) next earnings date is currently unknown.

  • Does Teva Pharmaceutical Industries Limited pay dividends?

    No, Teva Pharmaceutical Industries Limited does not pay dividends.

  • How much money does Teva Pharmaceutical Industries Limited make?

    Teva Pharmaceutical Industries Limited has a market capitalization of 12.22B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 6.17% to 15.85B US dollars. Teva Pharmaceutical Industries Limited made a loss 559M US dollars in net income (profit) last year or -$0.39 on an earnings per share basis.

  • What is Teva Pharmaceutical Industries Limited's stock symbol?

    Teva Pharmaceutical Industries Limited is traded on the OTC under the ticker symbol "TEVJF".

  • What is Teva Pharmaceutical Industries Limited's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.

  • How do i buy shares of Teva Pharmaceutical Industries Limited?

    Shares of Teva Pharmaceutical Industries Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Teva Pharmaceutical Industries Limited have?

    As Jul 2024, Teva Pharmaceutical Industries Limited employs 35,001 workers.

  • When Teva Pharmaceutical Industries Limited went public?

    Teva Pharmaceutical Industries Limited is publicly traded company for more then 15 years since IPO on 18 Jun 2010.

  • What is Teva Pharmaceutical Industries Limited's official website?

    The official website for Teva Pharmaceutical Industries Limited is tevapharm.com.

  • How can i contact Teva Pharmaceutical Industries Limited?

    Teva Pharmaceutical Industries Limited can be reached via phone at +972 3 914 8213.

Teva Pharmaceutical Industries Limited company profile:

Teva Pharmaceutical Industries Limited

tevapharm.com
Exchange:

OTC

Full time employees:

34,004

Industry:

Drug Manufacturers—Specialty & Generic

Sector:

Healthcare

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also manufactures and sells active pharmaceutical ingredients, as well as provides contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. In addition, it focuses on the central nervous system (CNS), pain, respiratory, and oncology areas. The company's products portfolio in the CNS field comprises Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; and AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; respiratory therapeutic area includes ProAir RespiClick, QVAR, ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease; and oncology therapeutic field consists of Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

124 Dvora Hanevi’a Street
Tel Aviv, 6944020

CIK: 0000818686
ISIN: IL0006290147
: